Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review.

PURPOSE: The current review aims to summarize the international experience of the impact of adaptive radiotherapy on dosimetry and clinical and toxicity outcomes. Additionally, it might trigger Radiation Oncologists to use ART and evaluate whether ART improves target volume coverage and/or normal tissue sparing and, consequently, therapeutic results. MATERIALS AND METHODS: We conducted an electronic literature search of PubMed/MEDLINE and ScienceDirect from January 2007 to January 2023. The search adhered to the PRISMA guidelines and employed keywords such as ART, HNC, parotid gland, and target volume. Furthermore, we examined the reference lists for studies pertinent to the present review. This study included both retrospective and prospective studies that were considered for inclusion. CONCLUSION: ART replanning appears to be a sustainable strategy to minimize toxicity by improving normal tissue sparing. Furthermore, it can enhance target volume coverage by correctly determining the specific dose to be delivered to the tumor. In conclusion, this review confirmed that ART benefits dosimetric, clinical/therapeutic, and toxicity outcomes.

Radiofrequency Exposure Levels in Greece.

Medical Physics Department (Medical School, University of Thessaly) participated in a Greek National EMF research program (EDBM34) with the scope to measure and evaluate radiofrequency (RF) exposure (27-3000 MHz) in areas of sensitive land use. A thousand (1000) measurements were carried out at two "metropolitan locations" (Athens and Thessaloniki: 624 points) and several rest urban/rural locations (376 points). SRM 3006 spectrum analyzer manufactured by Narda Safety Test Solutions was used. The broadband mean electric field in metropolitan areas was 0.41 V/m, while in the rest of Greece was 0.36 V/m. In metropolitan areas, the predominant RF source was the TV and Radio FM signals (36.2% mean contribution to the total RF exposure level). In the rest areas, the predominant source was the systems of the meteorological and military/defensive service (31.1%). The mobile sector contributed 14.9% in metropolitan areas versus 12.2% in the rest of Greece. The predominant mobile source was 900 MHz in both cases (4.5% in metropolitan areas vs. 3.3% in the rest of Greece). The total exposure from all RF sources complied with the International Commission on Non-Ionizing Radiation Protection (ICNIRP) 2020 safety guidelines [ICNIRP, 2020]. The maximum exposure level was 0.129% of the limit for the metropolitan areas vs. 0.110% for the rest of Greece. Nonremarkable differences between metropolitan areas' exposure and the rest of Greece. In most cases, new 5 G antennas will be added to the existing base stations. Thus, the total exposure may be increased, leading to higher safety distances. © 2023 Bioelectromagnetics Society.

The prevalence of a false-positive myocardial perfusion stress SPET test in a skinny patient, induced by projection truncation.

During the last decade, technical developments in myocardial perfusion single photon emission tomography (SPET) imaging systems have significantly improved the accuracy of diagnosing coronary artery disease. Nevertheless, the patient's position and/or the acquisition protocol can affect the studies' quality, possibly leading to misdiagnoses. In HJNM and in other journals the importance of proper positioning of the heart of the patient to be examined by myocardial perfusion SPET stress/rest testing, has been emphasized. According to our knowledge, only three cases of truncation artifact during SPET myocardial perfusion imaging acquired with original SPET cameras, related to improper positioning in very thin patients, have been reported. In all cases, patients were examined according to a single day stress/rest technetium-99m-sestamibi protocol, using a dual 90 degree detector system, equipped with high resolution, parallel-hole collimators. However, several published manuscripts have underlined the significance of appropriate patients' positioning in myocardial perfusion scintigraphy using dedicated, cadmium-zinc-telluride (CZT) or small field-of-view cardiac SPET systems. A typical case is that of a 47 years old man (height 187cm, weight 67kg), heavy smoker, with atypical chest pain. He exercised very well according to the Bruce protocol, achieving 95% of maximal age-predicted heart-rate and a technetium-99m-tetrofosmin ((99m)Tc-TF) myocardial perfusion imaging with 370MBq of (99m)Tc-TF followed with a dual head camera (Infinia GE, USA), equipped with low-energy, high-resolution, parallel-hole collimators at 90° (L-mode configuration). Projection images were obtained from 45° RAO to 45° LPO position, in step and shoot mode (60 projections, 30sec per projection; matrix 64×64 and zoom 1.3). Auto body contour was not used. Unprocessed raw data, showed neither patient motion nor significant extracardiac activity that could result in false positive defects on myocardial perfusion stress images. However, truncation at the apex of the heart was observed. In detail, truncation of activity of apical portion of the heart from frame 45-60 (detector 1) and frames 1-5 (detector 2) was noticed. Processed stress images demonstrated a severe defect in the apex and the apical part of the anteroseptal wall. Moreover, less intense defects were observed in the inferior and septal walls. All acquisition parameters were double checked and a possible error regarding the "zoom" was ruled out. Hence, it became evident that the aforementioned artifact has originated from an eccentric patient's position and thus some heart projections were missed. A second stress acquisition was performed after repositioning the patient with emphasis on positioning the heart at the center of the field of view. As a result, improvement of the above mentioned defects, mainly in the apex and the apical anteroseptal wall. In the literature, a number of recent studies have mentioned the effect of the truncation artifact even with newly equipped gamma cameras, emphasizing the importance of the heart being in the field of view throughout the acquisition procedure. Few of them used parallel-hole collimation. In conclusion, it is suggested that in cases of very thin patients it is often necessary to avoid truncation artefacts by correctly positioning the patient's heart.

Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.

OBJECTIVES: The aim of this study is to evaluate the feasibility and the related toxicity of hypofractionated whole-breast irradiation with a concomitant daily boost in early breast cancer women not eligible for accelerated partial-breast irradiation. METHODS: Twenty-seven patients received 46 Gy to the whole breast in 20 fractions/4 weeks with 2.3 Gy/fraction plus an additional concomitant daily boost of 0.4 Gy to the tumor bed, giving a total dose of 54 Gy (EQD2=60 Gy). The cosmetic outcome was assessed according to the European Organization for Research and Treatment of Cancer and Radiation Therapy Oncology Group grading system. RESULTS: Three months after the end of radiotherapy, 59.2% and 40.7% of patients showed grade 0 skin toxicity and grade 1 skin toxicity, respectively. After 6 months, 70.4% and 29.6% of patients showed grade 0 and grade 1 skin toxicity. After 1 year, grade 0 skin toxicity was found in 77.7% of the patients and grade 1 skin toxicity in 22.2% of the patients. After 18 months, grade 0 skin toxicity was found in 92.6% and grade 1 skin toxicity in 7.4% of the patients. After a median follow-up of 24 months, all patients showed excellent cosmetic results with minimal breast edema and minimal skin changes. There have been no local relapses to date. CONCLUSION: The accelerated hypofractionated schedule with a concomitant boost appears to be an acceptable alternative to the traditional longer schedule, with low local toxicity and excellent to good short-term cosmetic results, although a much longer follow-up is needed to assess the local control rate.

Comparison of two radiotherapeutic hypofractionated schedules in the application of tumor bed boost.

AIM: Evaluation of related radiation toxicity and efficacy in terms of local control of 2 radiotherapeutic hypofractionated schedules in the application of tumor bed boost by using 2 different planning techniques. METHOD: Eighty-one patients with stage I-II disease were retrospectively selected with either concomitant (group A) or sequential (group B) boost for the tumor bed. In group A, 27 patients were treated with a total dose of 46 Gy to the whole breast and 54 Gy to the tumor bed in 20 concomitant fractions. In group B, 54 patients were treated with a total dose of 42.4 Gy in 16 fractions to the whole breast and 53 Gy to the tumor bed by 4 sequential fractions. The boost was administered with multiple photon-beam fields. The median follow-up time was 24 months. RESULTS: The statistical analysis for the 2 groups of the study showed that skin toxicity was significantly worse in group A (P < .05, Kruskal-Wallis H test). For groups A and B at the completion of radiation therapy, grade 1 skin toxicity was observed in 18/27 patients (66.6%) and 13/54 patients (24.1%), respectively, whereas grade 2/3 was observed in 9/27 patients (33.3%) vs. 5/54 patients (9.3%), respectively (P < .001). One year after irradiation, in group A and in group B, the skin toxicity was of grade 1 in 6/27 patients (22.2%) vs. 2/54 patients (3.7%), respectively (P = .008). Within 2 years, the breast returned to its original form in all patients. No patient showed local disease recurrence. CONCLUSIONS: The accelerated hypofractionated schedules in the application of the tumor bed boost by using the 2 different planning techniques appears to be effective and well tolerated.

Optimisation of Radiation Exposure to Gastroenterologists and Patients during Therapeutic ERCP.

This study intended to optimize the radiation doses for gastroenterologists and patients during therapeutic endoscopic retrograde cholangiopancreatography (ERCP) and to compare the doses based on available data obtained by other researchers. A total of 153 patients were studied in two Gastroenterology Departments, (group A, 111; group B, 42). Thermoluminescent dosimeters (TLD) were used to measure the staff and patients entrance surface air kerma (ESAK) at different body sites. The mean ESAK and effective doses per procedure were estimated to be 68.75 mGy and 2.74 mSv, respectively. Staff was exposed to a heterogonous doses. The third examiner (trainee) was exposed to a high dose compared with other examiners because no shield was located to protect him from stray radiation. Patients and examiners doses were lower compared to the lowest values found in previous studies taking into consideration the heterogeneity of patients and equipment. Staff doses during ERCP are within the safety limit in the light of the current practice.

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature.

PURPOSE: Connective vascular diseases (CVD), including scleroderma, are reported to represent for some researchers a relative contraindication and for others absolute contraindication for radiotherapy. The purpose of our study is to add four new cases to the existing body of international literature and to determine whether women with pre-existing scleroderma who have been surgically treated for early breast cancer could undergo postsurgical radiotherapy without serious early and late complications. PATIENTS AND METHODS: From May 1998 to November 2010, we irradiated for early breast cancer four patients suffering from pre-existing scleroderma; after conservative surgery, we performed whole breast postoperative radiotherapy of 50.4 Gy total dose to the whole breast plus a 9 Gy boost to the tumor bed. We reviewed the records of all four patients and evaluated the early and late reactions using acute radiation morbidity scoring criteria (Radiation Therapy Oncology Group [RTOG], American College of Radiology, Philadelphia, PA) and late radiation morbidity scoring scheme (European Organisation for Research and Treatment of Cancer [EORTC], Brussels, Belgium and RTOG). RESULTS: After a median follow-up of 105 months (range 12-155 months) the early and late toxicity concerning the skin, the subcutaneous tissues, the lungs, and the heart have been acceptable and are in full accordance with what have been reported in international literature. CONCLUSION: This study matches global experience, which shows that patients with scleroderma and breast cancer must be discussed by the multidisciplinary tumor board in order for a personalized treatment strategy to be formulated. Radiation therapy can be proposed as a postsurgical therapeutic option in selected cases.

Reduction of radiation doses to patients and staff during endoscopic retrograde cholangiopancreatography.

BACKGROUND/AIM: Endoscopic retrograde cholangiopancreatography (ERCP) is associated with a considerable radiation exposure for patients and staff. While optimization of the radiation dose is recommended, few studies have been published. The purpose of this study has been to measure patient and staff radiation dose, to estimate the effective dose and radiation risk using digital fluoroscopic images. Entrance skin dose (ESD), organ and effective doses were estimated for patients and staff. MATERIALS AND METHODS: Fifty-seven patients were studied using digital X-ray machine and thermoluminescent dosimeters (TLD) to measure ESD at different body sites. Organ and surface dose to specific radiosensitive organs was carried out. The mean, median, minimum, third quartile and the maximum values are presented due to the asymmetry in data distribution. RESULTS: The mean ESD, exit and thyroid surface dose were estimated to be 75.6 mGy, 3.22 mGy and 0.80 mGy, respectively. The mean effective dose for both gastroenterologist and assistant is 0.01 mSv. The mean patient effective dose was 4.16 mSv, and the cancer risk per procedure was estimated to be 2 × 10(-5). CONCLUSION: ERCP with fluoroscopic technique demonstrate improved dose reduction, compared to the conventional radiographic based technique, reducing the surface dose by a factor of 2, without compromising the diagnostic findings. The radiation absorbed doses to the different organs and effective doses are relatively low.

On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy.

In this study we sought to evaluate and accent the importance of radiobiological parameter selection and implementation to the normal tissue complication probability (NTCP) models. The relative seriality (RS) and the Lyman-Kutcher-Burman (LKB) models were studied. For each model, a minimum and maximum set of radiobiological parameter sets was selected from the overall published sets applied in literature and a theoretical mean parameter set was computed. In order to investigate the potential model weaknesses in NTCP estimation and to point out the correct use of model parameters, these sets were used as input to the RS and the LKB model, estimating radiation induced complications for a group of 36 breast cancer patients treated with radiotherapy. The clinical endpoint examined was Radiation Pneumonitis. Each model was represented by a certain dose-response range when the selected parameter sets were applied. Comparing the models with their ranges, a large area of coincidence was revealed. If the parameter uncertainties (standard deviation) are included in the models, their area of coincidence might be enlarged, constraining even greater their predictive ability. The selection of the proper radiobiological parameter set for a given clinical endpoint is crucial. Published parameter values are not definite but should be accompanied by uncertainties, and one should be very careful when applying them to the NTCP models. Correct selection and proper implementation of published parameters provides a quite accurate fit of the NTCP models to the considered endpoint.

Peripheral dose measurement in high-energy photon radiotherapy with the implementation of MOSFET.

AIM: To study the peripheral dose (PD) from high-energy photon beams in radiotherapy using the metal oxide semiconductor field effect transistor (MOSFET) dose verification system. METHODS: The radiation dose absorbed by the MOSFET detector was calculated taking into account the manufacturer's Correction Factor, the Calibration Factor and the threshold voltage shift. PD measurements were carried out for three different field sizes (5 cm × 5 cm, 10 cm × 10 cm and 15 cm × 15 cm) and for various depths with the source to surface distance set at 100 cm. Dose measurements were realized on the central axis and then at distances (1 to 18 cm) parallel to the edge of the field, and were expressed as the percentage PD (% PD) with respect to the maximum dose (d(max)). The accuracy of the results was evaluated with respect to a calibrated 0.3 cm(3) ionization chamber. The reproducibility was expressed in terms of standard deviation (s) and coefficient of variation. RESULTS: % PD is higher near the phantom surface and drops to a minimum at the depth of d(max), and then tends to become constant with depth. Internal scatter radiation is the predominant source of PD and the depth dependence is determined by the attenuation of the primary photons. Closer to the field edge, where internal scatter from the phantom dominates, the % PD increases with depth because the ratio of the scatter to primary increases with depth. A few centimeters away from the field, where collimator scatter and leakage dominate, the % PD decreases with depth, due to attenuation by the water. The % PD decreases almost exponentially with the increase of distance from the field edge. The decrease of the % PD is more than 60% and can reach up to 90% as the measurement point departs from the edge of the field. For a given distance, the % PD is significantly higher for larger field sizes, due to the increase of the scattering volume. Finally, the measured PD obtained with MOSFET is higher than that obtained with an ionization chamber with percentage differences being from 0.6% to 34.0%. However, when normalized to the central d(max) this difference is less than 1%. The MOSFET system, in the early stage of its life, has a dose measurement reproducibility of within 1.8%, 2.7%, 8.9% and 13.6% for 22.8, 11.3, 3.5 and 1.3 cGy dose assessments, respectively. In the late stage of MOSFET life the corresponding values change to 1.5%, 4.8%, 11.1% and 29.9% for 21.8, 2.9, 1.6 and 1.0 cGy, respectively. CONCLUSION: Comparative results acquired with the MOSFET and with an ionization chamber show fair agreement, supporting the suitability of this measurement for clinical in vivo dosimetry.

Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects.

BACKGROUND: This study aimed to examine whether EBV seropositive patients with lung cancer have an altered virus-specific CTL response, as compared to age-matched healthy controls and whether any variation in this response could be attributed to senescence. METHODS: Peripheral blood mononuclear cells from lung cancer patients, age-matched and younger healthy individuals were used to measure EBV-specific CTLs after in vitro amplification with the GLCTLVAML and RYSIFFDYM peptides followed by HLA-multimer staining. RESULTS: Lung cancer patients and aged-matched controls had significantly lesser EBV-specific CTL than younger healthy individuals. Multimer positive populations from either group did not differ with respect to the percentage of multimer positive CTLs and the intensity of multimer binding. CONCLUSIONS: This study provides evidence that patients with lung cancer exhibit an EBV-specific CTL response equivalent to that of age-matched healthy counterparts. These data warrant the examination of whether young individuals have a more robust anti-tumor response, as is the case with the anti-EBV response.

Patient-specific internal radionuclide dosimetry.

The development of patient-specific treatment planning systems is of outmost importance in the development of radionuclide dosimetry, taking into account that quantitative three-dimensional nuclear medical imaging can be used in this regard. At present, the established method for dosimetry is based on the measurement of the biokinetics by serial gamma-camera scans, followed by calculations of the administered activity and the residence times, resulting in the radiation-absorbed doses of critical organs. However, the quantification of the activity in different organs from planar data is hampered by inaccurate attenuation and scatter correction as well as because of background and organ overlay. In contrast, dosimetry based on quantitative three-dimensional data can be more accurate and allows an individualized approach, provided that all effects that degrade the quantitative content of the images have been corrected for. In addition, inhomogeneous organ accumulation of the radionuclide can be detected and possibly taken into account. The aim of this work is to provide adequate information on internal emitter dosimetry and a state-of-the-art review of the current methodology and future trends.

A radionuclide dosimetry toolkit based on material-specific Monte Carlo dose kernels.

OBJECTIVE: We sought to develop a user-friendly dosimetry toolkit that should aid the improvement of the quality of radionuclide therapy, which is critically dependent on patient-specific planning of each treatment. METHODS: In this work, we present a new toolkit suitable for indicative radionuclide dose calculation. The software is built using open source tools and it uses dose kernels calculated using the Geant4 Application for Tomographic Emission simulation toolkit. In addition, a method that uses kernel data to extract a material-specific dose absorption factor is described and a proof of concept is given. In this work, time dependency and organ sensitivity are not modeled. RESULTS: The developed software utilizes Monte Carlo calculated dose kernels and proposes a fast dose calculation method. Using computed tomography or magnetic resonance imaging it can provide a more accurate and personalized indicative dose map. CONCLUSION: Dosimetry based on quantitative three-dimensional data is more accurate and allows a more individualized approach in patient therapy. Moreover, the use of this toolkit with the standardization for data collection and processing will increase the accuracy as well as the compatibility of radiation dose.

Dosimetric and radiobiological evaluation of dose distribution perturbation due to head heterogeneities for Linac and Gamma Knife stereotactic radiotherapy.

INTRODUCTION: In SRT/SRS, dedicated treatment planning systems are used for the calculation of the dose distribution. The majority of these systems utilize the standard TMR/OAR formalism for dose calculation as well as they usually neglect any perturbation due to head heterogeneities. The aim of this study is to examine the errors due to head heterogeneities for both absolute and relative dose distributions in stereotactic radiotherapy. MATERIALS AND METHODS: Dosimetric measurements in phantoms have been made for linac stereotactic irradiation. CT-based phantoms have been used for Monte Carlo simulations for both linac-based stereotactic system and Gamma Knife unit. Absolute and relative dose distributions have been compared between homogeneous and heterogeneous media. DVH and TCP results are presented for all cases. RESULTS: The maximum absolute dose difference at the isocenter was 2.2% and 6.9% for the linac and Gamma Knife respectively. The impact of heterogeneity in the target DVH was minor for the linac technique whereas considerable difference was observed for the Gamma Knife treatment. This was reflected also to the radiobiological evaluation, where the maximum TCP difference for the linac system was 2.7% and for the Gamma Knife was 4%. DISCUSSION AND CONCLUSIONS: The errors rising from the existence of head heterogeneities are not negligible especially for the Gamma Knife which uses lower energy beams. The errors of the absolute dose calculation could be easily eliminated by implementing a simple heterogeneity correction algorithm at the TPS. Nevertheless, the errors for not taking into account the lateral electron transport would require a more sophisticated approach and even direct Monte Carlo calculation.

Geometrical pre-planning for conformal radiotherapy.

The optimum selection of beams and arcs in conformal techniques is of the outmost importance in modern radiotherapy. In this work we give a description of an analytic method to aid optimum selection, which is based on minimizing the intersection between beams and organs at risk (OAR) and on minimizing the intersection between the beam and the planning target volume (PTV). An arc-selection function that permits selection of irradiation arcs based on individual beam feasibility is introduce. The method simulates the treatment process by defining a computed beam feasibility, for every possible set of gantry-table angles, by taking into account accurately computer intersection volumes between the OAR and beams. The beams are shaped to conform the target using realistic parameters for the treatment process. The results are displayed on a virtual sphere centred at the isocenter with color-coded regions indicating beam feasibility. Arcs selections are performed by searching the map for successive gantry positions at a certain table angle, with feasibility values greater than a user-specified threshold. The accuracy of the method was confirmed by using geometrical regular shapes, as well as real clinical cases.

NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.

This work aims to evaluate the predictive strength of the relative seriality, parallel and Lyman-Kutcher-Burman (LKB) normal tissue complication probability (NTCP) models regarding the incidence of radiation pneumonitis (RP), in a group of patients following lung cancer radiotherapy and also to examine their correlation with pulmonary function tests (PFTs). The study was based on 47 patients who received radiation therapy for stage III non-small-cell lung cancer. For each patient, lung dose volume histograms (DVHs) and the clinical treatment outcome were available. Clinical symptoms, radiological findings and pulmonary function tests incorporated in a post-treatment follow-up period of 18 months were used to assess the manifestation of radiation induced complications. Thirteen of the 47 patients were scored as having radiation induced pneumonitis, with RTOG criteria grade 3 and 28 of the 47 with RTOG criteria grade 2. Using this material, different methods of estimating the likelihood of radiation effects were evaluated, by analysing patient data based on their full dose distributions and associating the calculated complication rates with the clinical follow-up records. Lungs were evaluated as a paired organ as well as individual lungs. Of the NTCP models examined in the overall group considering the dose distribution in the ipsilateral lung, all models were able to predict radiation induced pneumonitis only in the case of grade 2 radiation pneumonitis score, with the LKB model giving the best results (chi2-test: probability of agreement between the observed and predicted results Pchi(chi2)=0.524 using the 0.05 significance level). The NTCP modelling considering lungs as a paired organ did not give statistically acceptable results. In the case of lung cancer radiotherapy, the application of different published radiobiological parameters alters the NTCP results, but not excessively as in the case of breast cancer radiotherapy. In this relatively small group of lung cancer patients, no positive statistical correlation could be established between the incidence of radiation pneumonitis as estimated by NTCP models and the pulmonary function test evaluation. However, the use of PFTs as markers or predictors for the incidence or severity of radiation induced pneumonitis must be investigated further.

Monte Carlo dosimetric evaluation of high energy vs low energy photon beams in low density tissues.

BACKGROUND AND PURPOSE: Low megavoltage photon beams are often the treatment choice in radiotherapy when low density heterogeneities are involved, because higher energies show some undesirable dosimetric effects. This work is aimed at investigating the effects of different energy selection for low density tissues. PATIENTS AND METHODS: BEAMnrc was used to simulate simple treatment set-ups in a simple and a CT reconstructed lung phantom and an air-channel phantom. The dose distribution of 6, 15 and 20 MV photon beams was studied using single, AP/PA and three-field arrangements. RESULTS: Our results showed no significant changes in the penumbra width in lung when a pair of opposed fields were used. The underdosage at the anterior/posterior tumor edge caused by the dose build-up at the lung-tumor interface reached 7% for a 5 x 5 cm AP/PA set-up. Shrinkage of the 90% isodose volume was noticed for the same set-up, which could be rectified by adding a lateral field. For the CT reconstructed phantom, the AP/PA set-up offered better tumor coverage when lower energies were used but for the three field set-up, higher energies resulted to better sparing of the lung tissue. For the air-channel set-up, adding an opposed field reduced the penumbra width. Using higher energies resulted in a 7% cold spot around the air-tissue interface for a 5 x 5 cm field. CONCLUSIONS: The choice of energy for treatment in the low density areas is not a straightforward decision but depends on a number of parameters such as the beam set-up and the dosimetric criteria. Updated calculation algorithms should be used in order to be confident for the choice of energy of treatment.

An inhomogeneity correction algorithm for irregular fields of high-energy photon beams based on Clarkson integration and the 3D beam subtraction method.

A number of treatment-planning systems still use conventional correction methods for body inhomogeneities. Most of these methods (power law method, tissue-air ratio (TAR), etc.) consider only on-axis points, rectangular fields, and inhomogeneous slabs covering the whole irradiating field. A new method is proposed that overcomes the above limitations. The new method uses the principle of the Clarkson method on sector integration to take into account the position and lateral extent of the inhomogeneity with respect to the point of calculation, as well as the shape of the irradiating field. The field is divided into angular sectors, and each sector is then treated separately for the presence of inhomogeneities using a conventional correction method. Applying this method, we can predict the correction factors for Co-60 and 6-MV photon beams for irregular fields that include inhomogeneities of lower or higher densities relative to water. Validation of the predicted corrections factors was made against Monte Carlo calculations for the same geometries. The agreement between the predicted correction factors and the Monte Carlo calculations was within 1.5%. In addition, the new method was able to predict the behavior of the correction factor when the point of calculation was approaching or moving away from the interface between two materials.

Analysis of the penumbra enlargement in lung versus the quality index of photon beams: a methodology to check the dose calculation algorithm.

It is well known that considerable underdosage can occur at the edges of a tumor inside the lung because of the degradation of penumbra due to lack of lateral electronic equilibrium. Although present even at smaller energies, this phenomenon is more pronounced for higher energies. Apart from Monte Carlo calculation, most of the existing Treatment Planning Systems (TPSs) cannot deal at all, or with acceptable accuracy, with this effect. A methodology has been developed for assessing the dose calculation algorithms in the lung region where lateral electronic disequilibrium exists, based on the Quality Index (QI) of the incident beam. A phantom, consisting of layers of polystyrene and lung material, has been irradiated using photon beams of 4, 6, 15, and 20 MV. The cross-plane profiles of each beam for 5x5, 10x10, and 25x10 fields have been measured at the middle of the phantom with the use of films. The penumbra (20%-80%) and fringe (50%-90%) enlargement was measured and the ratio of the widths for the lung to that of polystyrene was defined as the Correction Factor (CF). Monte Carlo calculations in the two phantoms have also been performed for energies of 6, 15, and 20 MV. Five commercial TPS's algorithms were tested for their ability to predict the penumbra and fringe enlargement. A linear relationship has been found between the QI of the beams and the CF of the penumbra and fringe enlargement for all the examined fields. Monte Carlo calculations agree very well (less than 1% difference) with the film measurements. The CF values range between 1.1 for 4 MV (QI 0.620) and 2.28 for 20 MV (QI 0.794). Three of the tested TPS's algorithms could not predict any enlargement at all for all energies and all fields and two of them could predict the penumbra enlargement to some extent. The proposed methodology can help any user or developer to check the accuracy of its algorithm for lung cases, based on a simple phantom geometry and the QI of the incident beam. This check is very important especially when higher energies are used, as the inaccuracies in existing algorithms can lead to an incorrect choice of energy for lung treatment and consequently to a failure in tumor control.